Download Free Sample Report

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

This report aims to provide a comprehensive presentation of the global market for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM). This report contains market size and forecasts of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) in global, including the following market information:

  • Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Revenue, 2018-2023, 2024-2030, ($ millions)
  • Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Sales, 2018-2023, 2024-2030, (K Units)
  • Global top five Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Insulin Pump Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) include Abbott Laboratories, Dexcom, GlySens Incorporated, Insulet Corp, Johnson & Johnson, Medtronic, Meiqi Medical Equipment, Microport and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Segment Percentages, by Type, 2022 (%)

  • Insulin Pump
  • Continuous Glucose Monitors (CGM)

Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Segment Percentages, by Application, 2022 (%)

  • Child
  • Adult
  • Elderly

Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Market Segment Percentages, By Region and Country, 2022 (%)

  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

  • Key companies Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) revenues in global market, 2018-2023 (Estimated), ($ millions)
  • Key companies Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) revenues share in global market, 2022 (%)
  • Key companies Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) sales in global market, 2018-2023 (Estimated), (K Units)
  • Key companies Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Abbott Laboratories
  • Dexcom
  • GlySens Incorporated
  • Insulet Corp
  • Johnson & Johnson
  • Medtronic
  • Meiqi Medical Equipment
  • Microport
  • Roche
  • Senseonics Holdings
  • SOOIL
  • Tandem Diabetes care

Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM), market overview.
Chapter 2: Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market size in revenue and volume.
Chapter 3: Detailed analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.